Contact PD/PI: Buchanan, Thomas A UL1 ABSTRACT The Southern California Clinical and Translational Science Institute (SC CTSI) is a multidisciplinary research institute housed at the University of Southern California and Children's Hospital Los Angeles. In partnership with the Los Angeles County Department of Health Services and broad based community health organizations throughout Los Angeles, SC CTSI seeks to be a leader in engaging diverse communities and special populations in clinical and translational research to improve their health. SC CTSI It is led by a team of experienced faculty and staff members who have deep experience in developing and supporting clinical and translational research. They propose to address issues of health across the lifespan, as well as challenges in clinical and translational research, by pursuing five specific aims are: (1) Engage diverse communities and special populations, their care providers and our researchers to establish clinical research priorities; identify barriers to research participation; and develop, demonstrate and disseminate innovative approaches to assure fully partnered clinical research across diverse communities and the lifespan; (2) Promote team science in clinical research by assembling interdisciplinary teams, including community members, to collaboratively design and conduct clinical studies and develop innovative approaches to address challenges in clinical research; (3) Expand workforce capacity and capabilities by training researchers, staff, and clinical and community partners in team-based research in diverse and special populations; (4) Streamline clinical research processes and create efficient systems to support safe and effective conduct of high quality local and multicenter clinical research, in particular in diverse clinical and community settings; and (5) Participate as an exemplary CTSA hub, conduct multi-site network studies, adopt successful models from CTSA peers and develop and disseminate innovative strategies throughout the CTSA network. We also bring special strengths in engaging diverse communities, digital innovation, and regulatory science to develop new approaches to overcome challenges in clinical research. Success in achieving our aims will create new solutions for health problems affecting some of the fasting growing and most vulnerable special populations in America, define new approaches to research with diverse communities, and contribute our deep experience and expertise to the national CTSA network. Project Summary/Abstract Page 73 Contact PD/PI: Buchanan, Thomas A UL1

Public Health Relevance

This application is for support of the Southern California Clinical and Translational Science Institute (SC CTSI). The SC CTSI is a multi-disciplinary institute housed at the University of Southern California and Children's Hospital Los Angeles. In partnership with the Los Angeles County Department of Health Services and broad based community health organizations in Los Angeles, the SC CTSI seeks to develop and support multidisciplinary clinical and translational research that will improve the health of diverse communities and address challenges in the conduct of clinical research with those communities. Project Narrative Page 74

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001855-05
Application #
9932172
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Rosemond, Erica K
Project Start
2016-07-01
Project End
2021-05-31
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Southern California
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Nagoshi, Makoto; Reddy, Swayta; Bell, Marisa et al. (2018) Low-dose dexmedetomidine as an adjuvant to propofol infusion for children in MRI: A double-cohort study. Paediatr Anaesth 28:639-646
Lang, Julie E; Ring, Alexander; Porras, Tania et al. (2018) RNA-Seq of Circulating Tumor Cells in Stage II-III Breast Cancer. Ann Surg Oncol 25:2261-2270
McLaughlin, Cory; Zagory, Jessica A; Fenlon, Michael et al. (2018) Timing of mortality in pediatric trauma patients: A National Trauma Data Bank analysis. J Pediatr Surg 53:344-351
Dieli-Conwright, Christina M; Parmentier, Jean-Hugues; Sami, Nathalie et al. (2018) Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention. Breast Cancer Res Treat 168:147-157
Jones, Ian A; Wilson, Melissa; Togashi, Ryan et al. (2018) A randomized, controlled study to evaluate the efficacy of intra-articular, autologous adipose tissue injections for the treatment of mild-to-moderate knee osteoarthritis compared to hyaluronic acid: a study protocol. BMC Musculoskelet Disord 19:383
Yu, Valerie; Bhattacharya, Dhruva; Webster, Andrew et al. (2018) Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results. Ocul Surf 16:478-486
Xiao, Ran; Shida-Tokeshi, Joanne; Vanderbilt, Douglas L et al. (2018) Electroencephalography power and coherence changes with age and motor skill development across the first half year of life. PLoS One 13:e0190276
Luo, Shan; O'Connor, Sydney G; Belcher, Britni R et al. (2018) Effects of Physical Activity and Sedentary Behavior on Brain Response to High-Calorie Food Cues in Young Adults. Obesity (Silver Spring) 26:540-546
Jiang, Crystal; Lane, Christianne J; Perkins, Emily et al. (2018) Determining if wearable sensors affect infant leg movement frequency. Dev Neurorehabil 21:133-136
RISE Consortium (2018) Impact of Insulin and Metformin Versus Metformin Alone on ?-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. Diabetes Care 41:1717-1725

Showing the most recent 10 out of 54 publications